-+ 0.00%
-+ 0.00%
-+ 0.00%

ELI LILLY: OVERALL SAFETY, TOLERABILITY PROFILE OF ORFORGLIPRON IN ATTAIN-MAINTAIN CONSISTENT WITH PREVIOUS ORFORGLIPRON PHASE 3 STUDIES

路透·12/18/2025 11:45:00

登录查看新闻详情